This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Case Western Reserve University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Dong Luo in Cancer Treatment
Introduction
Dong Luo is an accomplished inventor based in Cleveland, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on targeted therapies that aim to improve patient outcomes.
Latest Patents
Dong Luo holds a patent for "PSMA ligand targeted compounds and uses thereof." This patent describes prostate-specific membrane antigen (PSMA) targeted compounds having a specific formula, nanoclusters formed thereof, pharmaceutical compositions comprising a plurality of these compounds, and methods for treating and detecting cancers in a subject. This innovation represents a promising advancement in cancer detection and treatment.
Career Highlights
Dong Luo is affiliated with Case Western Reserve University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to revolutionize cancer therapies and improve the lives of patients.
Collaborations
He collaborates with notable colleagues, including James P Basilion and Clemens Burda, who contribute to his research efforts and enhance the impact of his innovations.
Conclusion
Dong Luo's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work exemplifies the potential of scientific research to make a meaningful difference in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile